Albert G. White III

Albert G. White III

DirectoratCooper Companies· In proxies 2021–2025

Pay in FY2023+15% from the year before · Cooper Companies stock +14.0% the same year

Albert G. White III was paid $13.5M in FY2023 (Oct), up 15%. Cooper Companies stock rose 14.0% that year.

Pay$100 in the stock at the end of FY20 → $98
Pay is from the Summary Compensation Table of each Cooper Companies proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. EvolusPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. Cooper CompaniesPublic company · 5 yr
    • Director2021 – Present · 5 yrStock in role -32%
  3. Melinta Therapeutics, IncPublic company
    • Director? – PresentNo stock prices for these years
  4. Y-mAbs Therapeutics, Inc.Public company · 8 yr
    • Director2017 – 2025 · 8 yrNo stock prices for these years
  5. Strongbridge Biopharma, PLCPublic company · 2 yr
    • Director2019 – 2021 · 2 yrNo stock prices for these years
  6. Strata Skin SciencesPublic company · 2 yr
    • Director2018 – 2020 · 2 yrNo stock prices for these years
  7. Cempra Inc.Public company · 8 yr
    • Director2012 – 2020 · 8 yrNo stock prices for these years
  8. Histogenics, Inc.Public company · 4 yr
    • Director2015 – 2019 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?